These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8822634)

  • 1. The Epstein-Barr virus (EBV) alters the B cell glycolipid which is recognized by the human monoclonal antibody to i-blood group antigen.
    Nagatsuka Y; Yamaki M; Watarai S; Yasuda T; Higashi H; Yamagata T; Ono Y
    Virus Res; 1996 Jul; 43(1):57-68. PubMed ID: 8822634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of human monoclonal antibodies to i blood group by EBV-induced transformation: possible presence of a new glycolipid in cord red cell membranes and human hematopoietic cell lines.
    Nagatsuka Y; Watarai S; Yasuda T; Higashi H; Yamagata T; Ono Y
    Immunol Lett; 1995 May; 46(1-2):93-100. PubMed ID: 7590936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-glycolipid antibodies produced by Epstein-Barr virus (EBV)-transformed oligoclonal B cell lines obtained from normal persons and autoimmune disease patients.
    Nagatsuka Y; Hanazawa S; Yasuda T; Ono Y
    Hum Antibodies Hybridomas; 1994; 5(3-4):183-6. PubMed ID: 7756582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a monoclonal antibody directed against Gb3Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells.
    Miyamoto D; Ueno T; Takashima S; Ohta K; Miyawaki T; Suzuki T; Suzuki Y
    Glycoconj J; 1997 Apr; 14(3):379-88. PubMed ID: 9147061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgG3 monoclonal antibody directed to an unbranched repeating type 2 chain (Gal beta 1----4GlcNAc beta 1----3Gal beta 1----4GlcNAc beta 1----3Gal beta 1----R) which is highly expressed in colonic and hepatocellular carcinoma.
    Miyake M; Kohno N; Nudelman ED; Hakomori S
    Cancer Res; 1989 Oct; 49(20):5689-95. PubMed ID: 2551493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.
    Slovin SF; Frisman DM; Tsoukas CD; Royston I; Baird SM; Wormsley SB; Carson DA; Vaughan JH
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2649-53. PubMed ID: 6283539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cell differentiation in Burkitt lymphoma lines. BLA: a glycolipid marker of B-cell differentiation.
    Balana A; Wiels J; Tetaud C; Mishal Z; Tursz T
    Int J Cancer; 1985 Oct; 36(4):453-60. PubMed ID: 3930411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy.
    Blaszczyk-Thurin M; Thurin J; Hindsgaul O; Karlsson KA; Steplewski Z; Koprowski H
    J Biol Chem; 1987 Jan; 262(1):372-9. PubMed ID: 2432062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicity.
    Taki T; Ogura K; Rokukawa C; Hara T; Kawakita M; Endo T; Kobata A; Handa S
    Cancer Res; 1991 Mar; 51(6):1701-7. PubMed ID: 1998961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolipid antigens of human polymorphonuclear neutrophils and the inducible HL-60 myeloid leukemia line.
    Symington FW; Hedges DL; Hakomori S
    J Immunol; 1985 Apr; 134(4):2498-506. PubMed ID: 3855933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens.
    Salahuddin SZ; Ablashi DV; Hunter EA; Gonda MA; Sturzenegger S; Markham PD; Gallo RC
    Int J Cancer; 1987 Feb; 39(2):198-202. PubMed ID: 3026971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G; Ehlin-Henriksson B; Schlossman SF
    J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes.
    Young LS; Dawson CW; Brown KW; Rickinson AB
    Int J Cancer; 1989 May; 43(5):786-94. PubMed ID: 2469656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
    Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor.
    Teneberg S; Lönnroth I; Torres López JF; Galili U; Halvarsson MO; Angström J; Karlsson KA
    Glycobiology; 1996 Sep; 6(6):599-609. PubMed ID: 8922955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of gangliosides from Theileria sergenti.
    Watarai S; Sugimoto C; Hosotani-Kaihara K; Kobayashi K; Onuma M; Lee JT; Kushi Y; Handa S; Yasuda T
    J Vet Med Sci; 1996 Nov; 58(11):1099-105. PubMed ID: 8959658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus.
    Sugden B; Metzenberg S
    J Virol; 1983 Jun; 46(3):800-7. PubMed ID: 6304342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.